{"id":18026,"date":"2023-04-28T12:55:33","date_gmt":"2023-04-28T12:55:33","guid":{"rendered":"https:\/\/d36deud6t4mnhi.cloudfront.net\/?page_id=18026"},"modified":"2024-03-15T11:12:42","modified_gmt":"2024-03-15T09:12:42","slug":"adverse-event-reporting","status":"publish","type":"page","link":"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/","title":{"rendered":"Adverse Event Reporting"},"content":{"rendered":"\n
\n
\n
\n
\n

<\/h2>\n

<\/p>\n \n

\n
\n \n
\n
\n
\n\n \n

Global<\/p>\n \n\n

\n ipsen_lsmv_intake_prod@arisglobal.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Algeria<\/p>\n \n\n

\n pharmacovigilance.algeria@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Australia<\/p>\n \n\n

\n pharmacovigilance.australia@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Austria<\/p>\n \n\n

\n pharmacovigilance.germany@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Belgium<\/p>\n \n\n

\n pharmacovigilance.belgium@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Brazil<\/p>\n \n\n

\n pharmacovigilance.brasil@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Canada<\/p>\n \n\n

\n pharmacovigilance.canada@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

China<\/p>\n \n\n

\n pharmacovigilance.china@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Hong Kong – PRC<\/p>\n \n\n

\n pharmacovigilance.hongkong@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Colombia<\/p>\n \n\n

\n pharmacovigilance.colombia@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Czech Republic<\/p>\n \n\n

\n pharmacovigilance.czech@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Denmark<\/p>\n \n\n

\n pharmacovigilance.nordic@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Estonia<\/p>\n \n\n

\n pharmacovigilance.baltic@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Finland<\/p>\n \n\n

\n pharmacovigilance.nordic@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

France<\/p>\n \n\n

\n pharmacovigilance.france@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Germany<\/p>\n \n\n

\n pharmacovigilance.germany@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Greece<\/p>\n \n\n

\n pharmacovigilance.greece@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Hungary<\/p>\n \n\n

\n pharmacovigilance.hungary@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Ireland<\/p>\n \n\n

\n pharmacovigilance.uk-ie@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Italy<\/p>\n \n\n

\n pharmacovigilance.italy@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Japan<\/p>\n \n\n

\n pv.japan@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Kazakhstan<\/p>\n \n\n

\n pharmacovigilance.kazakhstan@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Latvia<\/p>\n \n\n

\n pharmacovigilance.baltic@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Lithuania<\/p>\n \n\n

\n pharmacovigilance.baltic@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Luxembourg<\/p>\n \n\n

\n pharmacovigilance.belgium@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Mexico<\/p>\n \n\n

\n pharmacovigilance.mexico@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Netherlands<\/p>\n \n\n

\n pharmacovigilance.netherlands@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Norway<\/p>\n \n\n

\n pharmacovigilance.nordic@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Poland<\/p>\n \n\n

\n pharmacovigilance.poland@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Portugal<\/p>\n \n\n

\n pharmacovigilance.portugal@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Romania<\/p>\n \n\n

\n pharmacovigilance.romania@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Russian Federation<\/p>\n \n\n

\n pharmacovigilance.russia@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Saudi Arabia<\/p>\n \n\n

\n pharmacovigilance.ksa@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Singapore<\/p>\n \n\n

\n pharmacovigilance.sg@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Slovakia<\/p>\n \n\n

\n pharmacovigilance.slovakia@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

South Korea<\/p>\n \n\n

\n pharmacovigilance.korea@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Spain<\/p>\n \n\n

\n pharmacovigilance.spain@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Sweden<\/p>\n \n\n

\n pharmacovigilance.nordic@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Switzerland<\/p>\n \n\n

\n pharmacovigilance.germany@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Taiwan<\/p>\n \n\n

\n pharmacovigilance.taiwan@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Tunisia<\/p>\n \n\n

\n pharmacovigilance.tunisie@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Ukraine<\/p>\n \n\n

\n pharmacovigilance.ukraine@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

United Kingdom<\/p>\n \n\n

\n pharmacovigilance.uk-ie@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

United States of America<\/p>\n \n\n

\n pharmacovigilance.usa@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n\n \n

Vietnam<\/p>\n \n\n

\n pharmacovigilance.vietnam@ipsen.com<\/a>\n <\/p>\n \n

<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div> <\/section>\n <\/div>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":57,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-18026","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"\nAdverse Event Reporting - Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adverse Event Reporting - Global\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-15T09:12:42+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/\",\"url\":\"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/\",\"name\":\"Adverse Event Reporting - Global\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/#website\"},\"datePublished\":\"2023-04-28T12:55:33+00:00\",\"dateModified\":\"2024-03-15T09:12:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Contact us\",\"item\":\"https:\/\/www.ipsen.com\/contact-us\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Adverse Event Reporting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/#website\",\"url\":\"https:\/\/www.ipsen.com\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adverse Event Reporting - Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/","og_locale":"en_US","og_type":"article","og_title":"Adverse Event Reporting - Global","og_url":"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/","og_site_name":"Global","article_modified_time":"2024-03-15T09:12:42+00:00","twitter_card":"summary_large_image","twitter_site":"@ipsengroup","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/","url":"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/","name":"Adverse Event Reporting - Global","isPartOf":{"@id":"https:\/\/www.ipsen.com\/#website"},"datePublished":"2023-04-28T12:55:33+00:00","dateModified":"2024-03-15T09:12:42+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/contact-us\/adverse-event-reporting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/"},{"@type":"ListItem","position":2,"name":"Contact us","item":"https:\/\/www.ipsen.com\/contact-us\/"},{"@type":"ListItem","position":3,"name":"Adverse Event Reporting"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/#website","url":"https:\/\/www.ipsen.com\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages\/18026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/comments?post=18026"}],"version-history":[{"count":21,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages\/18026\/revisions"}],"predecessor-version":[{"id":52045,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages\/18026\/revisions\/52045"}],"up":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages\/57"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/media?parent=18026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}